1)ISO Nanotechnologies-Terminology and definitions for nanoparticles. ISO-TS 27687. 2008
|
|
|
2)Song Y, Li X , Du X. Exposure to nanoparticles is related to pleural effusion, pulmonary fibrosis and granuloma. Eur Respi J. 2009; 34: 559-67
|
|
|
3)Song Y, Li X, Wang L, et al. Nanomaterials in humans: identification, characteristics, and Potential damage. Toxicol Pathol. 2011; 39: 841-9
|
|
|
4)Morimoto Y, Kobayashi N, Shinohara N, et al. Hazard assessments of manufactured nanomaterials. J Occup Health. 2010; 52: 325-34
|
|
|
5)Morimoto Y, Horie M, Kobayashi N, et al. Inhalation toxicity assessment of carbon-based nanoparticles. Acc Chem Res. 2013; 46: 770-81
|
|
|
6)Oberdörster G, Oberdörster E, Oberdörster J. Nano-toxicology: An emerging discipline evolving from studies of ultrafine particles. Environ Health Perspect. 2005; 113: 823-40
|
|
|
7)森本泰夫, 田中勇武. ナノ粒子の有害性評価. 産業衛生学雑誌. 2008; 50: 37-48
|
|
|
8)Ghio AJ, Kim C, Devlin RB. Concentrated ambient air particles induce mild pulmonary inflammation in healthy human volunteers. Am J Respir Crit Care Med. 2000; 162: 981-8
|
|
|
9)Oberdörster G, Ferin J, Gelein R, et al. Role of the alveolar macrophage in lung injury: Studies with ultrafine particles. Environ Health Perspect. 1992; 97: 193–9
|
|
|
10)Heinrich U, Fuhst R, Rittinghausen S, et al. Chronic inhalation exposure of Wistar rats and two different strains of mice to diesel engine exhaust, carbon black, and titanium dioxide. Inhal Toxicol. 1995; 7: 533-56
|
|
|
11)Poland CA, Duffin R, Kinloch I, et al. Carbon nanotubes introduced into the abdominal cavity of mice show asbestos-like pathogenicity in a pilot study. Nat Nanotechnol. 2008; 3: 423-8
|
|
|
12)Donaldson K, Murphy FA, Duffin R, et al. Asbestos, carbon nanotubes and the pleural mesothelium: a review of the hypothesis regarding the role of long fibre retention in the parietal pleura, inflammation and mesothelioma. Part Fibre Toxicol. 2010; 7: 5
|
|
|
13)IARC monographs on the evaluation of carcinogenic risks to humans, volume 81. Man-made vitreous fibres. Lyon: IARC press; 2002
|
|
|
14)Elder A, Gulein R, Silva V, et al. Translocation of inhaled ultrafine manganese oxide particles to the central nervous system. Environ Health Perspect. 2006; 114: 1172-8
|
|
|
15)森本泰夫, 堀江祐範, 北島信一, 他. 工業用ナノ材料の有害性評価に向けた気管内投与試験と吸入ばく露試験の所見の比較. 日本衛生学会雑誌. 2013; 68: 161-7
|
|
|
16)Shi H, Magaye R, Castranova C, et al. Titanium dioxide nanoparticles: a review of current toxicological data. Part Fibre Toxicol. 2013; 10: 15
|
|
|
17)Shinohara N, Nakazato T, Tamura M, et al. Clerance kinetics of fullerene C60 exposure. Toxicol. 2010; 118: 564-73
|
|
|
18)Kwon JK, Hwang SK, Jin H, et al. Body distribution of inhaled fluorescent magnetic nanoparticles in the mice. J Occup Health. 2008; 50: 1-6
|
|
|
19)Zhu MT, Feng WY, Wang Y, et al. Particokinetics and extrapulmonary translocation of intratracheally ferric oxide nanoparticles in rats and the potential health risk assessment. Toxicol. 2009; 107: 342-51
|
|
|
20)Kreyling WG, Semmler-Behnke M, Seitz J, et al. Size dependence of the translocation of inhaled iridium and carbon nanoparticle aggregates from the lung of rats to the blood and secondary target organs. Inhal Toxicol. 2009; 21 Suppl 1: 55-60
|
|
|
21)Jackson P, Hougaard KS, Boisen AMZ, et al. Pulmonary exposure to carbon black by inhalation or instillation in pregnant mice: Effect on liver DNA strand breaks in dams and offspring. Nanotoxicol. 2012; 6: 486-500
|
|
|
22)中西準子, 編.ナノ材料リスク評価書—カーボンナノチューブ(CNT)—最終報告版:ナノ粒子特性評価手法の研究開発2011.8.17; NEDOプロジェクト(P06041)
|
|
|
23)蒲生昌志,編.ナノ材料リスク評価書—二酸化チタン(TiO2)—最終報告版:ナノ粒子特性評価手法の研究開発2011.7.22; NEDOプロジェクト(P06041)
|
|
|